5 Stories We Are Following Today 3-17-25
In this episode, Scott Becker covers five key stories, including the top five companies by market cap, standout stocks from Friday’s trading, struggling retail stocks, and more.
UK Growth Stops, EU Response to Trump + Several Stocks We Follow 3-15-25
In this episode, Scott Becker discusses the UK’s slowing economy, the EU’s response to Trump’s trade policies, and key stock market movers—including Palantir, Peloton, and Tempus AI.
IPO Uncertainty: Market Volatility and Capital Trends with Matt Wolf of RSM 3-14-25
In this episode, Matt Wolf, Healthcare Senior Analyst at RSM, breaks down the latest market trends, including declining equity values, IPO delays, and the increasing reliance on private capital.
3 Quick Stories + Elon Musk’s Scorecard 3-14-25
In this episode, Scott Becker covers three key market stories, including Oscar Health and RH stock drops, before discussing his updated Elon Musk scorecard.
Should We Reduce Government Spending: Twitter Poll Results 3-14-25
In this episode, Scott Becker discusses the results of a Twitter poll on government spending, where 78% of respondents favored reductions. He also gives special shoutouts to standout business leaders and investment funds making an impact.
8 Stories We Are Following Today 3-14-25
In this episode, Scott Becker breaks down eight key stories impacting markets, including government shutdown risks, shifting investor strategies, private equity trends, and major corporate moves from Intel and Starbucks.
4 Reader Questions 3-13-25
In this episode, Scott Becker answers four reader questions, covering the impact of private equity on GI practices, the effects of health system consolidation on costs, how healthcare leaders can navigate a potential recession, and the role of physical therapy as a strategic service.
The Government Shutdown, Tariffs, DOGE & More 3-13-25
In this episode, Scott Becker discusses the looming government shutdown, the complexities of trade wars and tariffs, and the debate around deficit spending.
The Elon Musk Score Card 3-13-25
In this episode, Scott Becker breaks down the latest Elon Musk scorecard, grading Tesla’s performance, X’s progress, SpaceX’s innovations, and even Musk’s contributions to population growth.
Tariffs, Uncertainty, and the Deal Market: Insights from Matt Wolf of RSM 3-12-25
In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, joins Scott Becker to discuss how tariffs and economic uncertainty are reshaping the deal-making landscape.